State laws

Delaware Drug Testing Laws for Employers

Delaware reverses the usual pattern. Most states write cannabis employment rules into the adult-use law and leave the medical program vague. Here the adult-use law disclaims any employment effect entirely, and the medical statute does the work — reaching the test result and then closing off the obvious defense.

No Testing Statute

Title 19 of the Delaware Code has no drug or alcohol testing chapter. Its chapters cover the Department of Labor, apprentices, union security agreements, child labor, employment practices, employee rights, minimum wage, wage payment and collection, public employment relations, whistleblowers, WARN and the Service Worker Protection Act — and nothing on testing.

So random, periodic, post-accident and pre-employment testing are all available with no statutory notice period, no policy approval, no laboratory mandate, no MRO requirement and no retest right. Delaware's workplace drug rules live entirely in its two cannabis statutes and the workers' compensation forfeiture provision.

Employing people in Delaware?Five questions, about a minute. A specialist follows up within one business day.

Request a Specialist

The Adult-Use Law Steps Aside

4 Del. C. 1304 is one sentence long and unusually clean: nothing in the chapter is intended to impact or impose any requirement or restriction on employers with respect to terms and conditions of employment including accommodation, policies, or discipline.

Section 1307 adds that nothing prohibits a person, employer, school, hospital, detention facility, corporation or other entity occupying, owning or controlling property from prohibiting or regulating possession, consumption, use, display, transfer, distribution, sale, transportation or growing of marijuana on that property, subject to narrow residential-lease exceptions. Section 1313 confirms the medical provisions are unaffected.

There is accordingly no off-duty-use protection for recreational users and no restriction on testing methodology from the adult-use side.

One currency note: Subchapter IX of the Act, covering consumer protection, is flagged in the Code as effective October 21, 2026, and several sections carry dual "effective until" and "effective October 21, 2026" versions. The Act is still phasing in, so a summary written earlier may be incomplete on the licensing side.

The Medical Statute Is the Whole Exposure

16 Del. C. 4905A(a)(3) is the provision to design around. Unless failing to do so would cost the employer a monetary or licensing-related benefit under federal law or regulations, an employer may not discriminate against a person in hiring, termination, or any term or condition of employment, or otherwise penalize a person, based on either:

  • the person's status as a cardholder; or
  • a registered qualifying patient's positive drug test for marijuana components or metabolites — unless the patient used, possessed, or was impaired by marijuana on the premises of the place of employment or during the hours of employment.

The second limb reaches the test result itself, not merely off-duty conduct. That already puts Delaware in the stricter category.

Then comes the part that makes it harder. 16 Del. C. 4907A(a)(3) provides that the presence of metabolites does not establish that a person was under the influence. So the statute gives you an exception for impairment at work, and simultaneously removes the evidence most employers would reach for to prove it.

What a Delaware Process Needs

A defined sequence before any cannabis-positive adverse action:

  1. Establish whether the person is a registered cardholder. The protection runs to cardholders, so this is the first fork.
  2. If they are, ask whether you have independent evidence of use, possession or impairment on the premises or during working hours. Documented observation, not the laboratory report.
  3. If you do not, consider whether the federal exception applies — a monetary or licensing-related benefit under federal law that would be lost by not acting.

DOT-regulated and other federally mandated populations are the clean path through all of this, because the federal exception does the work directly. For everyone else, the supervisor's contemporaneous documentation is what the case turns on.

Workers' Compensation Will Not Rescue It

19 Del. C. 2353(b) bars recovery where an employee is injured as a result of their own intoxication, deliberate and reckless indifference to danger, willful intention to bring about injury, or willful failure or refusal to use a reasonable safety appliance or perform a statutory duty — and states expressly that the burden of proof under this subsection shall be on the employer.

Two things follow. The bar requires the injury to be "as a result of" the intoxication, so a positive test alone is unlikely to carry it. And for a registered qualifying patient, the metabolite rule in 4907A(a)(3) undercuts the inference directly. Do not lean on the compensation forfeiture as a substitute for evidence in a metabolite-only cannabis case.

Where This Lands

Delaware's employment base is concentrated in financial services and credit card operations, chemicals and advanced materials, pharmaceuticals and life sciences, healthcare, poultry processing and agriculture, and port logistics and distribution. Poultry processing and chemicals carry genuinely safety-sensitive work where impairment evidence matters most — and where the metabolite rule means the supervisor documentation has to exist before the test result comes back, not after.

Common questions

Does Delaware have a drug testing statute?

No. Title 19 of the Delaware Code, covering labor, has no drug or alcohol testing chapter. There is no statutory probable-cause standard, no policy-approval step, no advance-notice period, no laboratory certification or confirmation requirement, no medical review officer mandate and no retest right for private-sector testing.

Does the adult-use law restrict us?

Not at all, and it says so. 4 Del. C. 1304, titled Places of employment, reads in full that nothing in the chapter is intended to impact or impose any requirement or restriction on employers with respect to terms and conditions of employment including accommodation, policies, or discipline.

What does the medical statute do?

It reaches the test result. 16 Del. C. 4905A(a)(3) provides that, unless failing to do so would cost the employer a monetary or licensing-related benefit under federal law, an employer may not discriminate against a person in hiring, termination or any term or condition of employment based on cardholder status or on a registered qualifying patient's positive drug test for marijuana components or metabolites — unless the patient used, possessed or was impaired by marijuana on the premises or during the hours of employment.

Can we prove impairment from the test?

Not from metabolites alone. 16 Del. C. 4907A(a)(3) provides that the presence of metabolites does not establish that a person was under the influence. So the statute reaches the result and then forecloses the easiest route to the exception, which means you need independent evidence of workplace use, possession or impairment.

Can we rely on the workers' compensation bar instead?

Not for a metabolite-only cannabis positive. 19 Del. C. 2353(b) requires that the injury be as a result of the employee's own intoxication and places the burden of proof on the employer. Combined with the metabolite rule, a positive test alone is a weak evidentiary basis.

Build Your Delaware Cardholder Process

Request a testing specialist

Answer five quick questions. There is no cost and no obligation.

Step 1 of 5

What do you need help with?

Select everything that applies.

How many employees does your company have?
Where are your employees?
When do you need testing in place?
Where should your specialist reach you?

A specialist will contact you within one business day. No cost, no obligation. We work with employers only.